Levofloxacin pharmacokinetics in adult cystic fibrosis. - Wikidata - wikimedia - TriplyDB

Levofloxacin pharmacokinetics in adult cystic fibrosis.

Levofloxacin pharmacokinetics in adult cystic fibrosis.

http://www.wikidata.org/entity/Q36137356

about

Prediction and analysis of the protein interactome in Pseudomonas aeruginosa to enable network-based drug target selection Dynamics of mutator and antibiotic-resistant populations in a pharmacokinetic/pharmacodynamic model of Pseudomonas aeruginosa biofilm treatment.Pharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients.The Novel CFTR Mutation A457P in a Male with a Delayed Diagnosis of Cystic Fibrosis Personalized therapeutics for levofloxacin: a focus on pharmacokinetic concerns.Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: III. fluoroquinolones.MP-376 (Aeroquin) for chronic Pseudomonas aeruginosa infections.Levofloxacin inhalation solution for the treatment of chronic Pseudomonas aeruginosa infection among patients with cystic fibrosis.Comparative pharmacokinetics of levofloxacin in healthy volunteers and in patients suffering from typhoid Fever.Probenecid, but not cystic fibrosis, alters the total and renal clearance of fexofenadine.

P2860

Q28481505-C800CEAA-8B42-4CAA-916B-4571638A0B87 Q31029779-0CE23AC2-D3C4-4B34-941D-EFA4B3D82E13 Q34297656-14D1B0CD-4F88-45CC-AE26-90BD20729FDB Q35614964-00B58FDD-8EB7-4C85-AFB9-8D5768B859A6 Q37678156-B13E2041-11E7-4C5F-AEA4-E6FA9413FB40 Q38040734-60FBF6C0-F7EA-4EE6-922C-05DB2D21E28F Q38061971-596A9EE7-287C-4DEA-8493-50C958760B03 Q38270626-60504D82-D4F5-42E1-BD28-1655129104EA Q40227798-02BA3792-BD7F-4034-8451-003EFD820C90 Q42436769-158373B7-EDAB-41F3-AB78-D0C26878F4A1

P2860

Levofloxacin pharmacokinetics in adult cystic fibrosis.

http://www.wikidata.org/entity/Q36137356

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Levofloxacin pharmacokinetics in adult cystic fibrosis.

@ast

Levofloxacin pharmacokinetics in adult cystic fibrosis.

@en

type

label

Levofloxacin pharmacokinetics in adult cystic fibrosis.

@ast

Levofloxacin pharmacokinetics in adult cystic fibrosis.

@en

prefLabel

Levofloxacin pharmacokinetics in adult cystic fibrosis.

@ast

Levofloxacin pharmacokinetics in adult cystic fibrosis.

@en

P1433

Q36137356-4B310946-162D-42C5-8CC0-9A5FEBE71644

P1476

Q36137356-669A16FA-6115-4FC8-A9BF-5E4880AD20CF

P2093

Q36137356-02180DC5-2607-4950-8572-02730BC7A6F5

Q36137356-3A36D995-64D7-42AF-B72C-CCEB2D4D98F7

Q36137356-450EB0AF-4910-4078-99BD-0D1519643CDD

Q36137356-F3BA12FA-EF93-4585-8996-01704045F5AE

P2860

Q36137356-0D88DA64-F30D-425A-83B7-518459002733

Q36137356-153026DC-5A14-45B5-B7DE-99B768035F5A

Q36137356-19F213AD-FA91-401C-82F2-C37B07ECC56A

Q36137356-2A50C042-4422-4671-84C4-9A5CE45780C9

Q36137356-2ADE3F95-BC57-4D38-BEA5-B1CA764D3120

Q36137356-2BC46672-7ABE-483C-8493-0E2D26D12425

Q36137356-34146F73-F42C-418E-ABFD-A698312B2C02

Q36137356-3A07E979-1EDD-4527-9F69-6CFA44F61FFE

Q36137356-3FE717ED-CB0F-4BF1-ADD4-1F8B5B620135

Q36137356-4121132D-E24C-46B7-802B-E1B905171A06

P304

Q36137356-F96D2859-0083-444E-B9BC-205F5CB1B315

P31

Q36137356-25D7519B-1CB8-4F5C-A163-7E1E3F537AC0

P356

Q36137356-F473EA3A-62E4-4F50-9C1C-9A6A86496229

P407

Q36137356-C945CDB1-1D12-43D9-B7A6-09991D933939

P433

Q36137356-E3F1F49A-EA50-442A-AE2D-39ED1D1024B5

P478

Q36137356-670D30FD-EE2B-41AB-84A6-818B8EEDE404

P50

Q36137356-03A0A732-9A21-4856-9192-AFDD075EB054

Q36137356-59AFCCB2-CABD-44B1-87AC-9E42209C4A9E

Q36137356-7A43CBB8-AEDA-4FB0-BA1C-6F346FE39C09

P577

Q36137356-B533F05F-C3A0-4EB1-9239-EF57B2E90DD7

P5875

Q36137356-DB2EEA5D-2EC8-4FC2-89DF-7CBC6006845B

P698

Q36137356-F0195EF0-FDFB-4E7A-BC0F-5B2AF63936D6

P921

Q36137356-5D88CD9D-2689-410A-AB2F-123BDD7D7785

P932

Q36137356-ECE0C5AE-BC9F-4FF8-A275-EE9AC688F582

P356

P1433

P1476

Levofloxacin pharmacokinetics in adult cystic fibrosis.

@en

P2093

Carlton K K Lee

http://www.w3.org/2001/XMLSchema#string

Lois Brass-Ernst

http://www.w3.org/2001/XMLSchema#string

Marie Diener-West

http://www.w3.org/2001/XMLSchema#string

Michelle Noschese

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy

Prediction of creatinine clearance from serum creatinine

In vitro and in vivo activities of levofloxacin against biofilm-producing Pseudomonas aeruginosa.

Gender differences in pharmacokinetics and pharmacodynamics.

Comparison of the fluoroquinolones based on pharmacokinetic and pharmacodynamic parameters.

The multidrug resistance and cystic fibrosis genes have complementary patterns of epithelial expression.

Steady-state plasma and bronchopulmonary concentrations of intravenous levofloxacin and azithromycin in healthy adults.

Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients.

Pharmacokinetic and pharmacodynamic activities of ciprofloxacin against strains of Streptococcus pneumoniae, Staphylococcus aureus, and Pseudomonas aeruginosa for which MICs are similar

P304

796-802

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1378/CHEST.06-1524

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

131

http://www.w3.org/2001/XMLSchema#string

P50

Marie Diener-West

Michael P Boyle

P577

2007-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6451285

http://www.w3.org/2001/XMLSchema#string

P698

17356095

http://www.w3.org/2001/XMLSchema#string

P921

cystic fibrosis

P932

2075103

http://www.w3.org/2001/XMLSchema#string